Physician

Stanley L Tao, M.D.

According to 2025 Medicare claims, Stanley Tao, M.D. (NPI: 1811934805) practices ophthalmology in the Toledo, OH market, with the plurality of this provider's patient population coming from Lucas, OH. This provider's primary affiliated billing organization is PROMEDICA CENTRAL PHYSICIANS (NPI: 1043270150; TIN: 341881137) and primary practice location at 43615-2100. Tao is affiliated with the ProMedica Health Network, Inc. (ACO ID: A3016) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Tao's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,174 traditional Medicare patients, billed 8,253 HCPCS/CPT codes, and received $1,414,322 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,187 prescription claims across 651 beneficiaries totaling $133,563 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 42 records totaling $1,341. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $63,059 to $133,563. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,192	6,096	$894,597
2016	1,176	5,333	$675,539
2017	1,267	5,167	$646,134
2018	1,182	4,913	$643,997
2019	1,156	4,857	$602,133
2020	1,077	4,334	$546,644
2021	1,140	4,470	$608,346
2022	1,181	5,125	$856,352
2023	1,205	5,459	$879,776
2024	1,174	8,253	$1,414,322

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	252	600	$63,059
2016	286	738	$59,599
2017	430	1,306	$107,133
2018	487	1,541	$136,596
2019	523	1,789	$145,401
2020	521	1,897	$173,164
2021	729	2,829	$259,664
2022	626	2,751	$255,819
2023	646	2,423	$222,997
2024	651	2,187	$133,563

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	205	205	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	656	872	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	582	898	$61
92134	Imaging of retina	769	1,578	$29
92250	Photography of the retina	306	327	$26

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	39	1,590	$33,340
Brimonidine Tartrate	Brimonidine Tartrate	127	7,374	$15,520
Latanoprost	Latanoprost	750	43,760	$10,304
Cyclosporine	Cyclosporine	13	870	$10,232
Prednisolone Acetate	Prednisolone Acetate	274	8,797	$7,846

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	42	$1,341	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Stanley L. Tao, M.D.?

Tedicare shows public-source Medicare data for Stanley L. Tao, M.D. (NPI 1811934805), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stanley L. Tao, M.D. have ACO affiliation data?

Stanley L. Tao, M.D. is shown with ACO affiliation data for ProMedica Health Network, Inc. (MSSP, ACO ID A3016) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Stanley L. Tao, M.D.?

Stanley L. Tao, M.D. is linked to PROMEDICA CENTRAL PHYSICIANS (billing NPI 1043270150) in the available physician profile data.

Does Stanley L. Tao, M.D. have Open Payments data?

Stanley L. Tao, M.D. has 42 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.